Company Profiles

driven by the PitchBook Platform

Telormedix

Description

Developer of immune selective drugs for the treatment of cancer and autoimmune diseases. The company is a biopharmaceutical company focused on targeted immunity and the role of the innate immune system in treating cancer and autoimmune diseases.

2007

Founded

PRIVATE

Status

1-10

Employees

Series B

Latest Deal Type

$6.71M

Latest Deal Amount

$33.6M

Total Amount Raised

Description

Developer of immune selective drugs for the treatment of cancer and autoimmune diseases. The company is a biopharmaceutical company focused on targeted immunity and the role of the innate immune system in treating cancer and autoimmune diseases.

Website:

www.telormedix.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals

Primary Office

Via della Posta 10 CH-6934 BioggioSwitzerland +41 (0)91 610 7000
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Telormedix's full profile, request a free trial.

Telormedix Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Telormedix Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
AravisVenture CapitalMinority000 0000000 0000
BSIInvestment BankMinority000 0000000 0000
ProQuest InvestmentsVenture CapitalMinority000 0000000 0000
Aravis Venture Capital
BSI Investment Bank
ProQuest Investments Venture Capital

Telormedix Executive Team (5)

NameTitleBoard
Seat
Contact
Info
Filippo RivaChief Financial Officer
Roberto MajFounder & Head, Drug Development
Raffaella PozziHead, Clinical Operations
Johanna Holldack MDChief Executive Officer & Board Member
Wylinn Boey Ph.DVice President, Marketing & Strategic Planning
Filippo Riva Chief Financial Officer
Roberto Maj Founder & Head, Drug Development
Raffaella Pozzi Head, Clinical Operations
Johanna Holldack MD Chief Executive Officer & Board Member
Wylinn Boey Ph.D Vice President, Marketing & Strategic Planning

Telormedix Board Members (4)

NameRepresentingRoleSinceContact
Info
Alain Schreiber MDProQuest InvestmentsPartner000 0000
Jean-Philippe TripetAravisFounder & Managing Partner000 0000
Johanna Holldack MDSelfChief Executive Officer & Board Member000 0000
Stuart Holden MDProQuest InvestmentsChairman of the Scientific Advisory Board000 0000
Alain Schreiber MD Partner ProQuest Investments
Jean-Philippe Tripet Founder & Managing Partner Aravis
Johanna Holldack MD Chief Executive Officer & Board Member Self
Stuart Holden MD Chairman of the Scientific Advisory Board ProQuest Investments
Request full access to PitchBook